郭帅

职称:助理研究员

电话:17694874242

邮箱:guoshuai@hbu.edu.cn

地址:河北省保定市五四东路180号,河北大学逸夫楼920实验室

邮政编码:071002

  • 个人简介

教育经历

2014.09-2020.07 工学博士 河北工业大学

2010.09-2014.07 理学学士 长治学院

 工作经历

 

2020.10至今    校聘研究员,河北大学

 奖励荣誉

 

2020年,河北省优秀博士论文

 执教课程

 

本科生《细胞生物学》,《细胞生物学实验》;研究生《细胞生物学研究进展》



科研领域

TMEM16A离子通道结构与功能关系,TMEM16A离子通道靶向药物分子设计

科研项目

1. 国家自然科学基金,82104224,2022/01-2024/12,主持

2. 河北省自然科学基金,C2021201025,2021/12-2023/12,主持

3. 中国博士后科学基金面上项目,2022M710998,2022/1-2023/12,主持

4. 河北省博士后择优资助重点项目,B2022005012,2022/1-2023/12,主持



代表性论文

1. Sun, W.#, Guo, S.#(共同一作), Li, Y.#, et al. Anoctamin 1 controls bone resorption by coupling Cl− channel activation with RANKL-RANK signaling transduction[J], Nature Communications, 2022, 13(1):2899.

2. Bai, X., Liu, X., Li, S., An, H., Kang, X., Guo, S.*. Caffeic Acid, an Active Ingredient in Coffee, Combines with DOX for Multitarget Combination Therapy of Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(27):8326-8337.

3. Guo, S., Bai, X., Shi, S., et al. Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma[J], Biomedicine & pharmacotherapy, 2022, 153:113392.

4. Bai, X., Li, S., Liu, X., An, H., Kang, X., Guo, S.*. Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(12):3687-3696.

5. Chang, L., Chang, R., Shen J., Wang, Y., Song, H., Kang, X., Zhao. Y., Guo, S.*, Qin, J*. Self-healing pectin/cellulose hydrogel loaded with limonin as TMEM16A inhibitor for lung adenocarcinoma treatment[ J]. International Journal of Biological Macromolecules, 2022, 219: 754-766.

6. Guo, S., Bai, X., Shi, S., et al. TMEM16A, a homoharringtonine receptor, as a potential endogenic target for lung cancer treatment[J], International Journal of Molecular Sciences, 2021, 22(20):10930.

7. Guo, S., Bai, X., Liu, Y.F., et al. Inhibition of TMEM16A by natural product silibinin: potential lead compounds for treatment of lung adenocarcinoma[J], Frontiers in Pharmacology, 2021, 12: 643489.

8. Guo, S., Chen, Y.F., Shi, S., et al. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy[J], Pharmacological Research, 2020, 155: 104721.

9. Guo, S., Chen, Y.F., Shi, S., et al. The molecular mechanism of ginsenoside analogs activating TMEM16A[J], Biophysical Journal, 2020, 118(1): 262-272.

10. Guo, S., Qiu, L., Chen, Y.F., et al. TMEM16A-inhibitor loaded pH-responsive nanoparticles: a novel dual-targeting antitumor therapy for lung adenocarcinoma[J], Biochemical Pharmacology, 2020,178:114062.

11. Guo, S., Wang, H., Pang, C.L., et al. Entering the spotlight: chitosan oligosaccharides as novel activators of CaCCs/TMEM16A[J], Pharmacological Research, 2019, 146: 104323.

12. Guo, S., Chen, Y.F., Pang, C.L., et al. Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects[J], Journal of Cellular Physiology, 2019, 234(6): 8698-8708.

13. Guo, S., Chen, Y.F., Pang, C.L., et al. Ginsenoside Rb1, a novel activator of the TMEM16A chloride channel, augments the contraction of guinea pig ileum[J], Pflugers Archiv : European Journal of Physiology, 2017, 469(5-6): 681-692.

14. Hao, A.Q.#, Guo, S.#(共同一作), Shi, S., et al. Emerging modulators of TMEM16A and their therapeutic potential[J], The Journal of Membrane Biology, 2021, 254(4): 353-365.

15. Huang, Y.Y.#, Guo, S.#(共同一作), Ren, S.X., et al. The natural compound cinnamaldehyde is a novel activator of calcium-activated chloride channel[J], The Journal of Membrane Biology, 2018, 251(5-6): 747-756.3.


书记信箱

院长信箱 jiangyon...

图书馆

教务系统

办公系统

诚聘英才